These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31680292)

  • 1. Liver Injury in Patients With Cholestatic Liver Disease Treated With Obeticholic Acid.
    Eaton JE; Vuppalanchi R; Reddy R; Sathapathy S; Ali B; Kamath PS
    Hepatology; 2020 Apr; 71(4):1511-1514. PubMed ID: 31680292
    [No Abstract]   [Full Text] [Related]  

  • 2. Obeticholic acid (Ocaliva) for primary biliary cholangitis.
    Med Lett Drugs Ther; 2017 Mar; 59(1517):53-55. PubMed ID: 28323811
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial: Advances in Hepatology: 2019.
    Rockey DC
    Curr Opin Gastroenterol; 2019 May; 35(3):135-136. PubMed ID: 30865044
    [No Abstract]   [Full Text] [Related]  

  • 4. Plecanatide, Nusinersen, and Obeticholic acid.
    Hussar DA; Douglas DK
    J Am Pharm Assoc (2003); 2017; 57(3):416-418. PubMed ID: 28506401
    [No Abstract]   [Full Text] [Related]  

  • 5. A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis.
    Nevens F; Andreone P; Mazzella G; Strasser SI; Bowlus C; Invernizzi P; Drenth JP; Pockros PJ; Regula J; Beuers U; Trauner M; Jones DE; Floreani A; Hohenester S; Luketic V; Shiffman M; van Erpecum KJ; Vargas V; Vincent C; Hirschfield GM; Shah H; Hansen B; Lindor KD; Marschall HU; Kowdley KV; Hooshmand-Rad R; Marmon T; Sheeron S; Pencek R; MacConell L; Pruzanski M; Shapiro D;
    N Engl J Med; 2016 Aug; 375(7):631-43. PubMed ID: 27532829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obeticholic Acid: First Global Approval.
    Markham A; Keam SJ
    Drugs; 2016 Aug; 76(12):1221-6. PubMed ID: 27406083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting liver-related serious adverse events in patients with primary biliary cholangitis-related cirrhosis treated with obeticholic acid.
    Londoño MC; Díaz-González Á
    Liver Int; 2022 Nov; 42(11):2356-2359. PubMed ID: 36162085
    [No Abstract]   [Full Text] [Related]  

  • 8. Improved Markers of Cholestatic Liver Injury in Patients With Primary Biliary Cholangitis Treated With Obeticholic Acid and Bezafibrate.
    Smets L; Verbeek J; Korf H; van der Merwe S; Nevens F
    Hepatology; 2021 Jun; 73(6):2598-2600. PubMed ID: 33140868
    [No Abstract]   [Full Text] [Related]  

  • 9. Excessive Dosing of Obeticholic Acid May Increase Risk of Liver Damage.
    Aschenbrenner DS
    Am J Nurs; 2018 Feb; 118(2):46. PubMed ID: 29369874
    [No Abstract]   [Full Text] [Related]  

  • 10. The Appropriate Timing and Dose of Obeticholic Acid in Patients With Primary Biliary Cirrhosis.
    Dong R; Zheng S; Chen G
    Gastroenterology; 2015 Aug; 149(2):508. PubMed ID: 26136168
    [No Abstract]   [Full Text] [Related]  

  • 11. Old and new treatments for primary biliary cholangitis.
    Chascsa D; Carey EJ; Lindor KD
    Liver Int; 2017 Apr; 37(4):490-499. PubMed ID: 28371104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Modern treatment of primary biliary cholangitis].
    Strassburg CP
    Internist (Berl); 2018 Jan; 59(1):105-112. PubMed ID: 29110023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Farnesoid X receptor agonists for primary biliary cirrhosis.
    Lindor KD
    Curr Opin Gastroenterol; 2011 May; 27(3):285-8. PubMed ID: 21297469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New name and new treatments for primary biliary cholangitits].
    Bossen L; Ytting H; Jepsen P; Hamberg O; Ott P; Grønbæk H
    Ugeskr Laeger; 2018 Mar; 180(10):. PubMed ID: 29536837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obeticholic acid for the treatment of primary biliary cholangitis.
    Ali AH; Lindor KD
    Expert Opin Pharmacother; 2016 Sep; 17(13):1809-15. PubMed ID: 27468093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obeticholic acid and budesonide for the treatment of primary biliary cirrhosis.
    Silveira MG; Lindor KD
    Expert Opin Pharmacother; 2014 Feb; 15(3):365-72. PubMed ID: 24382005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obeticholic acid in primary biliary cholangitis: where we stand.
    Manne V; Kowdley KV
    Curr Opin Gastroenterol; 2019 May; 35(3):191-196. PubMed ID: 30844895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of primary biliary cholangitis prior to obeticholic acid availability.
    Durazzo M; Bonetto S; Fagoonee S; Morgando A; Pellicano R
    Minerva Med; 2018 Dec; 109(6):410-417. PubMed ID: 30022645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary biliary cholangitis: Old and novel therapy.
    Floreani A; Mangini C
    Eur J Intern Med; 2018 Jan; 47():1-5. PubMed ID: 28669591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary biliary cirrhosis in adults.
    Momah N; Lindor KD
    Expert Rev Gastroenterol Hepatol; 2014 May; 8(4):427-33. PubMed ID: 24580040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.